Death is typically a final destination ordeal. Once you take your last breath and are declared dead, that's it, right? Well, not quite because Victoria Thomas had a different experience where she ...

“A lot of people thought the brain after clinical death was inactive or hypoactive,” said Dr. Jimo Borjigin, who led the study. “But we show that’s definitely not the case.

Allogene revised its LBCL trial after a fatal adverse event linked to ALLO-647, shifting to a standard FC regimen and updating its clinical approach.

A Neonatal Intensive Care Unit (NICU) clinical director is supporting calls for a law change mandating medication be checked ...

About 1 in 6 patients with GG1 prostate cancer have a higher risk of prostate cancer-specific death, data suggest.

Background: The clinical utility of risk scores to guide treatment decisions and improve clinical outcomes has rarely been prospectively evaluated. This study aimed to evaluate whether a ...